The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...
Takeda has reported positive results from a phase 3 trial of its experimental therapy TAK-755 for ultra-rare disease congenital thrombotic thrombocytopenic purpura (cTTP), setting up regulatory ...
Ablynx is preparing to a US filing for its caplacizumab for the rare, life-threatening blood clotting disorder acquired thrombotic thrombocytopenic purpura (aTTP) following additional data from a ...
A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac Biotech and immune thrombotic thrombocytopenic purpura ...
Both hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are characterized by thrombotic microangiopathy (TMA), affecting mainly the kidney and brain, respectively.
Risk for thrombotic microangiopathy (including hemolytic uremic syndrome and thrombotic thrombocytopenic purpura) esp. in those with severe infections, GVHD, HLA mismatch. Elderly. Labor & delivery.